作者: David M. Levy , Kyle A. Petersen , Margie Scalley Vaught , David R. Christian , Brian J. Cole
DOI: 10.1016/J.ARTHRO.2018.02.022
关键词: Platelet-rich plasma 、 Transplantation 、 Viscosupplementation 、 Stem cell 、 Mesenchymal stem cell 、 Medicine 、 Corticosteroid 、 Reimbursement 、 Internal medicine 、 Osteoarthritis
摘要: This article reviews the benefits of corticosteroid, viscosupplementation, platelet-rich plasma, and autologous mesenchymal stem cell injections for treatment patients with knee osteoarthritis. Integrating into both clinical surgical practices is complicated given existing health insurance reimbursement policies. review describes outcomes associated these interventions appropriate methods navigating pathways to help providers implement treatments their practices.